Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NEOG · against 349 other Healthcare companies of similar size
Ranked #247 of 350 · scores higher than 29% of peers
Bars: peers in each 10-point band of the profitability score24 peers with a profitability score of 30–39, including NEOG · Click a bar to see the companies
Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | NEOG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 331 reported | -0.2% | 7.0% | 28% | 33% | |
| Operating marginHigher is better · 325 reported | -0.8% | 9.4% | 26% | 33% | |
| Return on assetsHigher is better · 334 reported | -1.7% | 2.5% | 30% | 33% | |
| Return on equityHigher is better · 323 reported | -2.7% | 6.3% | 33% | Context only | |
| Gross marginHigher is better · 360 reported | 47.4% | 47.7% | 49% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 242 | 2.5B USD | 38 | 32 | |
| 245 | 20.7B CNY (≈$2.9B) | 37 | 51 | |
| 245 | 15.3B CNY (≈$2.1B) | 37 | 57 | |
| 247 | 15.8B HKD (≈$2.0B) | 36 | 61 | |
| 247 | 2.6B USD | 36 | 32 | |
| 249 | 11.6B HKD (≈$1.5B) | 35 | 36 | |
| 249 | 1.7B USD | 35 | 35 | |
| 249 | 2.0B USD | 35 | 27 | |
| 252 | 9.6B CNY (≈$1.3B) | 34 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score